Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ChiCTR |
Last refreshed on:
|
19 March 2018 |
Main ID: |
ChiCTR1800015174 |
Date of registration:
|
2018-03-12 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Effects of Vitamin D supplementation on clinical prognosis for patients with Crohn's disease
|
Scientific title:
|
Effects of Vitamin D supplementation on clinical prognosis for patients with Crohn's disease |
Date of first enrolment:
|
2018-05-01 |
Target sample size:
|
control group:32;Vitamin D:32; |
Recruitment status: |
Pending |
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=19597 |
Study type:
|
Interventional study |
Study design:
|
Randomized parallel controlled trial
|
Phase:
|
New Treatment Measure Clinical Study
|
|
Countries of recruitment
|
China
| | | | | | | |
Contacts
|
Name:
|
Shixue Dai
|
Address:
|
106 Second Zhongshan Road, Guangzhou, Guangdong, China
510080
|
Telephone:
|
+86 13760653948 |
Email:
|
shixuedai@hotmail.com |
Affiliation:
|
Guangdong General Hospital |
|
Name:
|
Ying Zheng
|
Address:
|
106 Second Zhongshan Road, Guangzhou, Guangdong, China
510080
|
Telephone:
|
+86 18565576287 |
Email:
|
jasmine.maki@163.com |
Affiliation:
|
Gudangdong General Hospital,Guangdong Academy of Medical Sciences |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: 1) Aged 18-75 years old;
2) Diagnosis of CD or UC must be based on the combine assessment of clinical manifestation, physical examination, laboratory examination, imaging study, esophagogastroduodenoscopy and pathology examination;
3) patients agree to and sign the information contact.
Exclusion criteria: 1. indeterminate colitis;
2. pregancy;
3. long-term alcoholic and/or drug dependence;
4. previous history of mental disease and/or emotional disturbance;
5. previous history of severe or chronic cardiovascular, respiratory, urinary, reproductive, endocrine, nervous, skeletal, muscular system disease;
6. patients refuse to sign information contact.
Age minimum:
18
Age maximum:
75
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Crohn's disease
|
Intervention(s)
|
control group:placebo;Vitamin D:800IU Vitamin D;
|
Primary Outcome(s)
|
CDAI;inflammatory factor;vitamin D level;
|
Secondary Outcome(s)
|
B vitamins;leptin ghrelin;
|
Source(s) of Monetary Support
|
Natural Science Foundation of China
|
Ethics review
|
Status: Approved
Approval date:
Contact:
Li-ming Yao
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|